Skip to content
healthcare.dev

Dihydroergotamine Mesylate Nasal

NDC 69097-503, Dihydroergotamine Mesylate Nasal, spray, metered, from Cipla USA Inc..

Product NDC
69097-503
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
SPRAY, METERED
Route
NASAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212907
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIHYDROERGOTAMINE MESYLATE4 mg/mL

Pharmacologic classes

Ergotamine Derivative [EPC]; Ergotamines [CS]

Package NDCNDC-11Package
69097-503-27690970503278 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL
69097-503-31690970503311 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1ecb2311-eee3-4230-a019-a3496308cff1
  • NADAC price for package 69097050327

    GET /v1/drugs/nadac/69097050327
  • NADAC price for package 69097050331

    GET /v1/drugs/nadac/69097050331

Use it

Look up 69097-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.